Balchem develops, manufactures, and distributes specialty ingredients for human nutrition, animal nutrition, and industrial markets. The company's core technologies are microencapsulation and chelation, which it applies across markets to improve how nutrients are delivered and absorbed. Balchem's largest segment, Human Nutrition and Health (~64% of revenue), supplies branded specialty nutrients — choline (VitaCholine), vitamin K2 (K2VITAL), MSM (OptiMSM), and chelated minerals (Albion Minerals) — to supplement and nutrition companies, and also sells customized food ingredient systems to food and beverage manufacturers. The Animal Nutrition and Health segment (~23% of revenue) sells encapsulated precision-release nutrients like rumen-protected choline to dairy farmers, and also sells choline chloride to the poultry, swine, and pet industries. The Specialty Products segment (~13% of revenue) repackages and distributes performance gases like ethylene oxide and propylene oxide, and sells chelated mineral products to growers of high-value crops. Balchem's business model centers on earning a premium over commodity alternatives by backing its branded ingredients with clinical science, which enables customers to make efficacy claims in their marketing. Balchem also invests in direct-to-consumer marketing, including sports sponsorships, to drive demand pull through the supply chain. Growth is driven by market penetration, geographic expansion (roughly 75% of sales are currently in the U.S.), and capacity investment, including a new microencapsulation facility expected to more than double capacity by 2027.